What does the evidence say about Lactoferrin Immune Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Lactoferrin Immune Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - As an integral component of the human diet, dairy products are rich in high-quality protein, lactoferrin, conjugated linoleic acid, calcium, vitamin D, and various other nutrients and bioactive compounds. [Wang M (2026); evidence level 4] - They exert broad health benefits through core mechanisms involving multiple pathways and targets. [Wang M (2026); evidence level 4] - The PICOS question was: 'Are lactoferrin levels different between individuals with periodontitis and periodontally healthy controls, and are these levels associated with disease severity and established clinical periodontal indicators, supporting their role as diagnostic or prognostic biomarkers for periodontitis?'. [Patil GV (2026); evidence level 4] - Egger's regression test produced a t-statistic of -0.646 (P=0.529), reflecting a lack of significant evidence for publication bias. [Patil GV (2026); evidence level 4] - In conclusion, lactoferrin showed potential as a biomarker for periodontal disease, with elevated levels consistently linked to its presence and disease severity. [Patil GV (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.